Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Antihypertensive peptides disclosed by Snow Brand

Dec. 13, 1996

Roussel Uclaf reports new quinoline derivatives

Dec. 13, 1996

Millennium/Lilly's gene-based assay for atherosclerosis

Dec. 12, 1996

NOS inhibitors described by Searle

Dec. 12, 1996

Therapeutically active NPY analog reported by academic source

Dec. 9, 1996

Oncogene Science issued patent on gene transcription

Dec. 6, 1996

Anti-E-selectin antisense compound from Isis inhibits mRNA splicing

Dec. 6, 1996

Cytel announces plans for Cylexin at investors conference

Dec. 5, 1996

New endothelin receptor modulators reported by Texas Biotechnology

Dec. 4, 1996

Once-daily antihypertensive combination cleared for marketing in Canada

Dec. 3, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Chengdu Mfs Pharma synthesizes new compounds for pain
BioWorld Science
Chengdu Mfs Pharma Co. Ltd. has prepared and tested compounds for the potential treatment of pain, sleep disorder and status epilepticus epilepsy as well as for...